The blood testing company was a media darling until a Wall Street Journal article took Theranos to task for its unreliable tests and unproven technology. You can see the story as 1) a deliciously schadenfreude-laden takedown of a blood testing company coasting on its young CEO’s charisma and black turtlenecks or 2) a light on the loopholes that allow medical test companies to sidestep FDA regulation, which frankly, is much more worrying.
Theranos Takes a Beating in the Press
The blood testing company was a media darling until a
Wall Street Journal article took Theranos to task for its unreliable tests and unproven technology.
Wall Street Journal article took Theranos to task for its unreliable tests and unproven technology.